Back to News
technology

AI Drug Discovery Startup Earendil Is Said to Consider Hong Kong IPO

Julia Fioretti, Amber Tong
Loading...
1 min read
0 likes
Untitled design (27).png
Quantum News · Media Library

Earendil Labs, a biotechnology startup that uses artificial intelligence for drug discovery, is considering listing in Hong Kong, according to people familiar with the matter.

Read Original

Tags

drug-discovery
quantum-investment
startup

Source Information

Source: Bloomberg Technology

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.